U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 229

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:6719415
GRCh38:
Chr19:6719404
C3Atypical hemolytic-uremic syndrome with C3 anomalyLikely pathogenic
(May 25, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr19:6712412
GRCh38:
Chr19:6712401
C3F375LAtypical hemolytic-uremic syndrome with C3 anomalyUncertain significance
(Jul 28, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr19:6692999
GRCh38:
Chr19:6692988
C3L1109RAtypical hemolytic-uremic syndrome with C3 anomalyUncertain significance
(Apr 1, 2023)
no assertion criteria provided
4.
GRCh37:
Chr19:6677938
GRCh38:
Chr19:6677927
C3not provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr19:6678018
GRCh38:
Chr19:6678007
C3G1623WComplement component 3 deficiency, not provided, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Uncertain significance
(Dec 16, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr19:6694465
GRCh38:
Chr19:6694454
C3G1044EAtypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency,
not provided
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr19:6713216
GRCh38:
Chr19:6713205
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Atypical hemolytic-uremic syndrome, not provided
Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
8.
GRCh37:
Chr19:6697650
GRCh38:
Chr19:6697639
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr19:6694605
GRCh38:
Chr19:6694594
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr19:6690622
GRCh38:
Chr19:6690611
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr19:6679520
GRCh38:
Chr19:6679509
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Likely benign
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr19:6713228
GRCh38:
Chr19:6713217
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr19:6707932
GRCh38:
Chr19:6707921
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr19:6679400
GRCh38:
Chr19:6679389
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr19:6681945
GRCh38:
Chr19:6681934
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Likely benign
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr19:6679235
GRCh38:
Chr19:6679224
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency,
not provided
Likely benign
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr19:6714097
GRCh38:
Chr19:6714086
C3Atypical hemolytic-uremic syndrome, not provided, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9, Complement component 3 deficiency
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr19:6697812
GRCh38:
Chr19:6697801
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency,
not provided
Likely benign
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr19:6707863
GRCh38:
Chr19:6707852
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr19:6710686
GRCh38:
Chr19:6710675
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Likely benign
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr19:6710630
GRCh38:
Chr19:6710619
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Benign/Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr19:6702463
GRCh38:
Chr19:6702452
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency,
not provided
Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr19:6718271
GRCh38:
Chr19:6718260
C3not provided, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Complement component 3 deficiency
Likely benign
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr19:6684416
GRCh38:
Chr19:6684405
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Benign/Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr19:6707866
GRCh38:
Chr19:6707855
C3not provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Likely benign
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr19:6712591
GRCh38:
Chr19:6712580
C3Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Likely benign
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr19:6710866
GRCh38:
Chr19:6710855
C3Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Likely benign
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr19:6707470
GRCh38:
Chr19:6707459
C3not provided, not specified, Complement component 3 deficiency,
Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Jul 26, 2023)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr19:6678432
GRCh38:
Chr19:6678421
C3not provided, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Complement component 3 deficiency
Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr19:6719273
GRCh38:
Chr19:6719262
C3not provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr19:6694581
GRCh38:
Chr19:6694570
C3not provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr19:6710985
GRCh38:
Chr19:6710974
C3not provided, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
Age related macular degeneration 9
Likely benign
(Jul 2, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr19:6702588
GRCh38:
Chr19:6702577
C3N750YAtypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Uncertain significance
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr19:6718408
GRCh38:
Chr19:6718397
C3E95KAge related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr19:6713227
GRCh38:
Chr19:6713216
C3V326MAge related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Uncertain significance
(Apr 4, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr19:6685110
GRCh38:
Chr19:6685099
C3not provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr19:6718317-6718318
GRCh38:
Chr19:6718306-6718307
C3L125fsComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Pathogenic/Likely pathogenic
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr19:6697483
GRCh38:
Chr19:6697472
C3P890SComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Uncertain significance
(May 26, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr19:6713304
GRCh38:
Chr19:6713293
C3V300AComplement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:6710650
GRCh38:
Chr19:6710639
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr19:6693083
GRCh38:
Chr19:6693072
C3Y1081Cnot provided, Complement component 3 deficiency, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr19:6690728
GRCh38:
Chr19:6690717
C3R1134QComplement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided, Atypical hemolytic-uremic syndrome
Uncertain significance
(Apr 28, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr19:6711203
GRCh38:
Chr19:6711192
C3R425Lnot provided, Age related macular degeneration 9, Complement component 3 deficiency,
Atypical hemolytic-uremic syndrome with C3 anomaly
Uncertain significance
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr19:6707899
GRCh38:
Chr19:6707888
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Uncertain significance
(Oct 15, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr19:6713259
GRCh38:
Chr19:6713248
C3R315QAge related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr19:6682236
GRCh38:
Chr19:6682225
C3R1393WComplement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(May 26, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr19:6694500
GRCh38:
Chr19:6694489
C3E1032Dnot provided, Age related macular degeneration 9, Complement component 3 deficiency,
Atypical hemolytic-uremic syndrome with C3 anomaly
Uncertain significance
(Dec 25, 2021)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr19:6702510
GRCh38:
Chr19:6702499
C3E776QAge related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr19:6709818
GRCh38:
Chr19:6709807
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency,
not provided
Likely benign
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr19:6694573
GRCh38:
Chr19:6694562
C3S1008Lnot provided, Atypical hemolytic-uremic syndrome with C3 anomalyUncertain significance
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr19:6690729
GRCh38:
Chr19:6690718
C3R1134WComplement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Apr 13, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr19:6718157
GRCh38:
Chr19:6718146
C3T151SComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr19:6679480
GRCh38:
Chr19:6679469
C3P1495Lnot provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Uncertain significance
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr19:6686290
GRCh38:
Chr19:6686279
C3R1219CComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Uncertain significance
(Apr 14, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr19:6679430
GRCh38:
Chr19:6679419
C3R1512CAtypical hemolytic-uremic syndrome with C3 anomalyLikely pathogenic
(Feb 14, 2019)
no assertion criteria provided
56.
GRCh37:
Chr19:6707214
GRCh38:
Chr19:6707203
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided, not specified
Likely benign
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr19:6707877
GRCh38:
Chr19:6707866
C3G637Rnot provided, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Complement component 3 deficiency
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr19:6713399
GRCh38:
Chr19:6713388
C3not provided, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Complement component 3 deficiency
Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:6694650
GRCh38:
Chr19:6694639
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Benign
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr19:6707567
GRCh38:
Chr19:6707556
C3Age related macular degeneration 9, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr19:6718128
GRCh38:
Chr19:6718117
C3R161Wnot provided, Atypical hemolytic-uremic syndrome with C3 anomalyPathogenic
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr19:6713238
GRCh38:
Chr19:6713227
C3K322Rnot provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Uncertain significance
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr19:6694472
GRCh38:
Chr19:6694461
C3R1042WComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Uncertain significance
(Mar 26, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr19:6677979
GRCh38:
Chr19:6677968
C3E1636QComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9,
not provided
Uncertain significance
(May 17, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr19:6686311
GRCh38:
Chr19:6686300
C3not provided, Complement component 3 deficiency, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly
Likely benign
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr19:6709809
GRCh38:
Chr19:6709798
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not specified, not provided
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr19:6684380
GRCh38:
Chr19:6684369
C3not provided, Complement component 3 deficiency, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly
Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr19:6678222
GRCh38:
Chr19:6678211
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr19:6686188
GRCh38:
Chr19:6686177
C3V1253Mnot provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Uncertain significance
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr19:6686191
GRCh38:
Chr19:6686180
C3V1252IAge related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr19:6711075
GRCh38:
Chr19:6711064
C3G468RAge related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
Atypical hemolytic-uremic syndrome with C3 anomaly, not provided
Uncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr19:6718386
GRCh38:
Chr19:6718375
C3R102Hnot provided, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
Age related macular degeneration 9
Uncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr19:6707128
GRCh38:
Chr19:6707117
C3R735QAtypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9,
not provided
Uncertain significance
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr19:6678430
GRCh38:
Chr19:6678419
C3N1556SAge related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr19:6686866
GRCh38:
Chr19:6686855
C3N1179KAtypical hemolytic-uremic syndrome with C3 anomalyUncertain significanceno assertion criteria provided
76.
GRCh37:
Chr19:6712611
GRCh38:
Chr19:6712600
C3R343CInborn genetic diseases, not provided, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency
Uncertain significance
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr19:6684607
GRCh38:
Chr19:6684596
C3D1362NComplement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Apr 28, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr19:6684786
GRCh38:
Chr19:6684775
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Uncertain significance
(Mar 19, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr19:6686207-6686208
GRCh38:
Chr19:6686196-6686197
C3Atypical hemolytic-uremic syndrome with C3 anomalyPathogenic
(Jan 3, 2020)
no assertion criteria provided
80.
GRCh37:
Chr19:6707525
GRCh38:
Chr19:6707514
C3A667TAge related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
not provided
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr19:6681954
GRCh38:
Chr19:6681943
C3K1450QComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9
Uncertain significance
(Mar 2, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr19:6697567
GRCh38:
Chr19:6697556
C3V862LAtypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9
Uncertain significance
(Jan 15, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr19:6697534
GRCh38:
Chr19:6697523
C3C873RAtypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, Complement component 3 deficiency
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr19:6690744
GRCh38:
Chr19:6690733
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9, not provided,
Complement component 3 deficiency
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr19:6690742
GRCh38:
Chr19:6690731
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
not provided
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr19:6685015
GRCh38:
Chr19:6685004
C3L1318Rnot provided, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly,
Complement component 3 deficiency
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr19:6684860
GRCh38:
Chr19:6684849
C3Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr19:6720675
GRCh38:
Chr19:6720664
C3Complement component 3 deficiency, Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr19:6712540
GRCh38:
Chr19:6712529
C3Atypical hemolytic-uremic syndrome with C3 anomaly, not provided, Complement component 3 deficiency,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr19:6711007
GRCh38:
Chr19:6710996
C3not provided, Complement component 3 deficiency, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly
Conflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr19:6710860
GRCh38:
Chr19:6710849
C3not provided, Complement component 3 deficiency, Age related macular degeneration 9,
Atypical hemolytic-uremic syndrome with C3 anomaly
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr19:6720644
GRCh38:
Chr19:6720633
C3Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
93.
GRCh37:
Chr19:6714013
GRCh38:
Chr19:6714002
C3I255VComplement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly, not provided,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Oct 16, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr19:6710828
GRCh38:
Chr19:6710817
C3A503Vnot provided, Complement component 3 deficiency, Atypical hemolytic-uremic syndrome with C3 anomaly,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Mar 13, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr19:6702188
GRCh38:
Chr19:6702177
C3D797AAtypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr19:6697505
GRCh38:
Chr19:6697494
C3Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9
Uncertain significance
(Mar 2, 2018)
criteria provided, single submitter
97.
GRCh37:
Chr19:6697481
GRCh38:
Chr19:6697470
C3Atypical hemolytic-uremic syndrome with C3 anomaly, not provided, Complement component 3 deficiency,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr19:6696589
GRCh38:
Chr19:6696578
C3Atypical hemolytic-uremic syndrome with C3 anomaly, not provided, Complement component 3 deficiency,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr19:6690722
GRCh38:
Chr19:6690711
C3N1136SAtypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency, Age related macular degeneration 9
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr19:6690718
GRCh38:
Chr19:6690707
C3not provided, Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency,
Age related macular degeneration 9
Conflicting interpretations of pathogenicity
(Mar 24, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination